School of Pharmacy
Associate professor / professor in pharmaceutics
The School of Pharmacy, Department of Pharmacy (Pharmaceutics), at the University of Oslo invites applications for an Associate Professorship/Professorship in Pharmaceutics. The School of Pharmacy takes part in the Life Science program at the University of Oslo.
The Department of Pharmacy is one of the three departments at the School of Pharmacy. It consists of two main research areas; social pharmacy and drug formulation and development (pharmaceutics). The latter area employs 4 professors, 1 associate professor, 1 professor emeritus, 1 professor II, 3 post doc. students, 10 Ph.D. students, 5 master students and 3 technicians and is organized in two research groups; SiteDel andPharmaLuxLab. The current position is affiliated with the latter group.
The Department offers courses in pharmaceutics at bachelor, master- and ph.d levels, including biopharmaceutics and production of non-sterile and sterile preparations.
The overall aim for the research in pharmaceutics is to develop nano- and microstructured drug formulations and new formulation technologies for the delivery of biopharmaceuticals and other active pharmaceutical ingredients (API). The research can be defined under the heading: “Development of nano- and microstructured drug formulations and new formulation technologies for improved functionality in drug delivery”.The main emphasize is improved functionality of drug delivery systems intended for the treatment of cancer and for the treatment of a broad spectrum of bacterial, fungal and viral infections. Research of this type presupposes novel strategies and requires expertise to be drawn from across the boundaries between the traditional disciplines of science. The research groups exploit a multitude of experimental methods and techniques. The experimental methodologies involve thermodynamic measurements (differential scanning calorimetry), dynamic light scattering measurements (particle size and charge), rheological and viscosimetric measurements, spectroscopic techniques (fluorescence, UV-Vis spectroscopy), freeze drying processes, microscopy (atomic force microscopy, light microscopy), spray drying technology as well as quantitative analytical techniques (HPLC, UHPLC, HPTLC, GC/GC-MS) and conventional processing and characterization methods for tablets and pellets. The overall techniques cover a size range from millimeter to the nanometer, and solid, semisolid and liquid dosage forms. The groups have a broad national- and international collaborative network within academia, pharmaceutical industry and hospitals.
The successful applicant should contribute to a strengthening of the research within“Development of nano- and microstructured drug formulations and new formulation technologies for improved functionality in drug delivery”.
Information about the research groupThe position is affiliated with the PharmaLuxLab research group. The main focus of thePharmaLuxLab research projects is development of nanostructured drug formulations for the delivery of pharmaceutical active ingredients with poor drugability (e.g., low solubility, poor stability, high aggregation probablility). The main emphazis is development and characterization of delivery systems based on polymeric micelles and cyclodextrins. The clinical applications are mainly cancer- and antimicrobial photodynamic therapy (PDT/aPDT). The primary sites for drug release are the oral cavity, skin (i.e., wounds) and tumors. The systems could however, also be applicable in other contexts including delivery of biomacromolecules.
Specialities:
Applicants, who at the time of appointment cannot provide documentary evidence of formal educational/ pedagogical qualifications, must acquire such qualifications during a period of two years.
Specific information about the positionThe research group wants to strengthen their research in selected areas and therefore candidates with a background in one or more of the following research fields are desired:
Ability and preference for working in teams are highly valued qualities and should be documented. The successful applicant should document that he/she has a national- and international collaborative network within academia and preferentially also involving pharmaceutical industry and hospitals.
Applicants are required to outline one or several research projects and show how these are expected to strengthen the scientific activities within the research group.
As a general rule an interview will be used in the appointment process, and it may be appropriate to require trial lectures. The basis for assessment will be the scholarly production of the applicant, other qualifications, pedagogical or educational, the applicant’s qualifications within leadership and administration as well as the general personal suitability. In ranking the competent applicants, the full range of qualifications will be considered and explicitly assessed. Cf. the Rules for appointments to associate professorships.
Rules for the assessment and weighting of pedagogical competence for appointments to permanent academic posts which include teaching duties.
Salary
The pay grade for position code 1011 and position code 1013 will be regulated by the Basic Collective Agreement for Employees in the Service of the State.
The application must include:
In accordance with the University of Oslo`s equal opportunities policy, we invite applications from all interested individuals regardless of gender or ethnicity.
The University of Oslo has an agreement for all employees, aiming to secure rights to research results.
The Department of Pharmacy is one of the three departments at the School of Pharmacy. It consists of two main research areas; social pharmacy and drug formulation and development (pharmaceutics). The latter area employs 4 professors, 1 associate professor, 1 professor emeritus, 1 professor II, 3 post doc. students, 10 Ph.D. students, 5 master students and 3 technicians and is organized in two research groups; SiteDel andPharmaLuxLab. The current position is affiliated with the latter group.
The Department offers courses in pharmaceutics at bachelor, master- and ph.d levels, including biopharmaceutics and production of non-sterile and sterile preparations.
The overall aim for the research in pharmaceutics is to develop nano- and microstructured drug formulations and new formulation technologies for the delivery of biopharmaceuticals and other active pharmaceutical ingredients (API). The research can be defined under the heading: “Development of nano- and microstructured drug formulations and new formulation technologies for improved functionality in drug delivery”.The main emphasize is improved functionality of drug delivery systems intended for the treatment of cancer and for the treatment of a broad spectrum of bacterial, fungal and viral infections. Research of this type presupposes novel strategies and requires expertise to be drawn from across the boundaries between the traditional disciplines of science. The research groups exploit a multitude of experimental methods and techniques. The experimental methodologies involve thermodynamic measurements (differential scanning calorimetry), dynamic light scattering measurements (particle size and charge), rheological and viscosimetric measurements, spectroscopic techniques (fluorescence, UV-Vis spectroscopy), freeze drying processes, microscopy (atomic force microscopy, light microscopy), spray drying technology as well as quantitative analytical techniques (HPLC, UHPLC, HPTLC, GC/GC-MS) and conventional processing and characterization methods for tablets and pellets. The overall techniques cover a size range from millimeter to the nanometer, and solid, semisolid and liquid dosage forms. The groups have a broad national- and international collaborative network within academia, pharmaceutical industry and hospitals.
The successful applicant should contribute to a strengthening of the research within“Development of nano- and microstructured drug formulations and new formulation technologies for improved functionality in drug delivery”.
Information about the research groupThe position is affiliated with the PharmaLuxLab research group. The main focus of thePharmaLuxLab research projects is development of nanostructured drug formulations for the delivery of pharmaceutical active ingredients with poor drugability (e.g., low solubility, poor stability, high aggregation probablility). The main emphazis is development and characterization of delivery systems based on polymeric micelles and cyclodextrins. The clinical applications are mainly cancer- and antimicrobial photodynamic therapy (PDT/aPDT). The primary sites for drug release are the oral cavity, skin (i.e., wounds) and tumors. The systems could however, also be applicable in other contexts including delivery of biomacromolecules.
Specialities:
- Photoreactivity of drugs and drug formulations
- Solubilization technology
- Nanovehicles such as cyclodextrins and polymeric micelles
- Solid state characterization (DSC, color measurements, hygroscopicity)
- Production of solid foams
- Formulation of supersaturated systems
Applicants, who at the time of appointment cannot provide documentary evidence of formal educational/ pedagogical qualifications, must acquire such qualifications during a period of two years.
Specific information about the positionThe research group wants to strengthen their research in selected areas and therefore candidates with a background in one or more of the following research fields are desired:
- Solubilization technology by application of nanovehicles and biopolymers
- Formulation of biomacromolecules
- Formulation of supersaturated systems
Ability and preference for working in teams are highly valued qualities and should be documented. The successful applicant should document that he/she has a national- and international collaborative network within academia and preferentially also involving pharmaceutical industry and hospitals.
Applicants are required to outline one or several research projects and show how these are expected to strengthen the scientific activities within the research group.
As a general rule an interview will be used in the appointment process, and it may be appropriate to require trial lectures. The basis for assessment will be the scholarly production of the applicant, other qualifications, pedagogical or educational, the applicant’s qualifications within leadership and administration as well as the general personal suitability. In ranking the competent applicants, the full range of qualifications will be considered and explicitly assessed. Cf. the Rules for appointments to associate professorships.
Rules for the assessment and weighting of pedagogical competence for appointments to permanent academic posts which include teaching duties.
Salary
The pay grade for position code 1011 and position code 1013 will be regulated by the Basic Collective Agreement for Employees in the Service of the State.
The application must include:
- Application letter
- CV and attachments
- Up to 10 selected scientific publications the applicant wishes to include in the evaluation
- List of scientific production with bibliographic references
- A portfolio containing documentation of teaching experience, capability of external fund raising and other qualifications the applicant wants to have considered
- A research plan describing the applicant’s scientific ambitions for the position
In accordance with the University of Oslo`s equal opportunities policy, we invite applications from all interested individuals regardless of gender or ethnicity.
The University of Oslo has an agreement for all employees, aiming to secure rights to research results.
- Region:
- Oslo
- Job type:
- Permanent
- Working hours:
- Full-time
- Working days:
- Day
- Application deadline:
- 6. January 2013
- Location:
- Blindern
- Reference number:
- 2012/13069
- Home page:
- http://www.farmasi.uio.no
- Contacts:
- Professor Hanne Hjorth Tønnesen
Telephone: +47 22856593 - Professor Sverre Arne Sande
Telephone: +47 22856590
